- Home
- ATXS vs BUI Comparison
ATXS vs BUI Comparison
Compare ATXS & BUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATXS | BUI |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.1M | 589.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATXS | BUI |
|---|---|---|
| Price | $12.96 | $26.10 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 59.8K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.75 |
| Revenue | ★ $706,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.56 | $18.73 |
| 52 Week High | $13.29 | $24.22 |
Technical Indicators
Market Signals| Indicator | ATXS | BUI |
|---|---|---|
| Relative Strength Index (RSI) | 65.10 | 48.87 |
| Support Level | $12.70 | $26.10 |
| Resistance Level | $13.29 | $26.14 |
| Average True Range (ATR) | 0.22 | 0.34 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 65.33 | 38.24 |
Price Performance
Historical ComparisonAbout ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About BUI BlackRock Utility Infrastructure & Power Opportunities Trust
BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing of writing (selling) call and put options.